Comparison Between Intralesional Meglumine Antimoniate and Combination of Trichloroacetic Acid 50% and Intralesional Meglumine Antimoniate in the Treatment of Acute Cutaneous Leishmaniasis: A Randomized Clinical Trial
Journal of Skin and Stem Cell · 2014
DOI: 10.17795/jssc16633 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Journal of Skin and Stem Cell, 2014. Verfasst von Mohammad Ali Nilforoushzadeh und 3 weiteren Autor:innen. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 25 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Nilforoushzadeh, M. A., Jaffary, F., Derakhshan, R., & Haftbaradaran, E. (2014). Comparison Between Intralesional Meglumine Antimoniate and Combination of Trichloroacetic Acid 50% and Intralesional Meglumine Antimoniate in the Treatment of Acute Cutaneous Leishmaniasis: A Randomized Clinical Trial. Journal of Skin and Stem Cell. https://doi.org/10.17795/jssc16633
Vancouver
Nilforoushzadeh MA, Jaffary F, Derakhshan R, Haftbaradaran E. Comparison Between Intralesional Meglumine Antimoniate and Combination of Trichloroacetic Acid 50% and Intralesional Meglumine Antimoniate in the Treatment of Acute Cutaneous Leishmaniasis: A Randomized Clinical Trial. Journal of Skin and Stem Cell. 2014. doi:10.17795/jssc16633
BibTeX
@article{Nilforoushzadeh2014,
author = {Nilforoushzadeh, Mohammad Ali and Jaffary, Fariba and Derakhshan, Roya and Haftbaradaran, Elaheh},
title = {Comparison Between Intralesional Meglumine Antimoniate and Combination of Trichloroacetic Acid 50% and Intralesional Meglumine Antimoniate in the Treatment of Acute Cutaneous Leishmaniasis: A Randomized Clinical Trial},
journal = {Journal of Skin and Stem Cell},
year = {2014},
doi = {10.17795/jssc16633}
}
EUVIMED